Jan Piek

Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry

Boerhout C, de Waard G, Lee JM, Mejía-Rentería H, Lee SH, Jung J, Hoshino M, Echavarria-Pinto M, Meuwissen M, Matsuo H, Madera-Cambero M, Efterkhari A, Effat M, Murai T, Marques K, Appelman Y, Doh J, Christiansen E, Banerjee R, Nam C, Niccoli G, Nakayama M, Tanaka N, Shin E, Beijk MA, Knaapen P, Escaned J, Kakuta T, Koo B, Piek J, van de Hoef TP

October 21, 2022 | 10.4244/EIJ-D-22-00043

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial

Ono M, Hara H, Kawashima H, Gao C, Wang R, Wykrzykowska JJ, Piek J, Garg S, Hamm C, Steg PG, Valgimigli M, Windecker S, Vranckx P, Onuma Y, Serruys P

August 5, 2022 | 10.4244/EIJ-D-21-00870

How to set up regional STEMI networks: a "Stent - Save a life!" initiative

Candiello A, Alexander T, Delport R, Toth G, Ong P, Snyders A, Belardi J, Lee M, Pereira H, Mohamed A, Mayol J, Piek J, Wijns W, Baumbach A, Naber C

March 18, 2022 | 10.4244/EIJ-D-21-00694

Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial

Kerkmeijer L, Renkens M, Tijssen R, Hofma S, van der Schaaf R, Arkenbout EK, Weevers A, Garcia-Garcia H, Kraak R, Piek J, Tijssen J, Henriques JP, de Winter RJ, Wykrzykowska JJ

March 18, 2022 | 10.4244/EIJ-D-21-00419

Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment

Seligman H, Nijjer S, van de Hoef TP, de Waard G, Mejía-Rentería H, Echavarria-Pinto M, Shun-Shin M, Howard J, Cook C, Warisawa T, Ahmad Y, Androshchuk V, Rajkumar C, Nowbar A, Kelshiker M, van Lavieren M, Meuwissen M, Danad I, Knaapen P, Sen S, Al-Lamee R, Mayet J, Escaned J, Piek J, van Royen N, Davies J, Francis D, Petraco R

February 18, 2022 | 10.4244/EIJ-D-21-00189

Principles and pitfalls in coronary vasomotor function testing

Feenstra R, Seitz A, Boerhout C, Bukkems L, Stegehuis V, Teeuwisse P, de Winter RJ, Sechtem U, Piek J, van de Hoef TP, Ong P, Beijk MA

February 18, 2022 | 10.4244/EIJ-D-21-00402

Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial

Faria D, Lee JM, van de Hoef TP, Mejía-Rentería H, Echavarria-Pinto M, Baptista S, Cerrato E, Garcia-Garcia H, Davies J, Onuma Y, Samady H, Piek J, Serruys P, Lerman A, Escaned J

October 20, 2021 | 10.4244/EIJ-D-20-01163

Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies

Stegehuis V, Wijntjens G, Bax M, Meuwissen M, Chamuleau S, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef TP

April 2, 2021 | 10.4244/EIJ-D-19-00774

Feasibility and reproducibility of renal flow reserve with combined pressure and flow velocity measurements

van Brussel P, van Lavieren M, Wijntjens G, Collard D, van Lienden K, Reekers J, Vogt L, Piek J, de Winter RJ, van den Born B

December 18, 2020 | 10.4244/EIJ-D-18-01101

Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial

Kraak R, Tijssen R, van Dongen I, Elias J, Hofma S, van der Schaaf R, Arkenbout EK, Weevers A, Tijssen J, Piek J, de Winter RJ, Henriques JP, Wykrzykowska JJ

December 4, 2020 | 10.4244/EIJ-D-18-00884

Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.

Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska JJ, Bullett N, Ahmed N, Al-Lamee R, Al-Lamee R, Leclerc G, Kitslaar P, Dijkstra J, Reiber J, Poon E, Bourantas C, Gijsen F, Serruys P, Onuma Y

June 12, 2020 | 10.4244/EIJ-D-18-01190

The SYNTAX score on its way out or … towards artificial intelligence: part I

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls NHJ, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarria-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli AL, Glocker B, Dressler O, Stone G, Onuma Y

May 20, 2020 | 10.4244/EIJ-D-19-00543A

The SYNTAX score on its way out or … towards artificial intelligence: part II

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls NHJ, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarria-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli AL, Glocker B, Dressler O, Stone G, Onuma Y

May 20, 2020 | 10.4244/EIJ-D-19-00543B

Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska JJ, Asano T, Kogame N, Takahashi K, Chang C, de Winter RJ, Serruys P, Wijns W

February 7, 2020 | 10.4244/EIJ-D-18-00944

Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation

Katagiri Y, Serruys P, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska JJ, Chevalier B, Mintz G, Stone G, Onuma Y

September 20, 2019 | 10.4244/EIJ-D-18-00422

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial

Kerkmeijer L, Tijssen R, Hofma S, van der Schaaf R, Arkenbout K, Kraak R, Weevers A, Piek J, de Winter RJ, Tijssen J, Henriques J, Wykrzykowska JJ, Ijsselmuiden A, Kauer F, Beijk MA, Vis MM, Koch K

September 20, 2019 | 10.4244/EIJ-D-19-00325

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska JJ, Piek J, Spitzer E, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study

Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska JJ, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Iñiguez A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y

June 12, 2019 | 10.4244/EIJ-D-18-00980

How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials

Katagiri Y, Serruys P, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska JJ, Piek J, Onuma Y

May 20, 2019 | 10.4244/EIJ-D-18-00607

Comprehensive physiological evaluation of epicardial and microvascular coronary domains using vascular conductance and zero flow pressure

van der Hoeven NW, de Waard G, Quiros A, de Hoyos A, Broyd C, Nijjer S, van de Hoef TP, Petraco R, Driessen R, Mejía-Rentería H, Kikuta Y, Echavarria-Pinto M, van de Ven P, Meuwissen M, Knaapen P, Piek J, Davies J, van Royen N, Escaned J

February 7, 2019 | 10.4244/EIJ-D-18-00021

Jan Piek

Latest news